Cargando…
Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab
INTRODUCTION: Amyloid‐related imaging abnormalities (ARIA) are a common, dose‐dependent effect of amyloid‐targeting antibodies, strongly associated with the apolipoprotein E (APOE) ε4 allele. METHODS: We describe the clinical course and management of a 66‐year‐old white male (APOE ε4/ε4) enrolled in...
Autores principales: | VandeVrede, Lawren, Gibbs, Daniel M, Koestler, Mary, La Joie, Renaud, Ljubenkov, Peter A., Provost, Karine, Soleimani‐Meigooni, David, Strom, Amelia, Tsoy, Elena, Rabinovici, Gil D., Boxer, Adam L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545921/ https://www.ncbi.nlm.nih.gov/pubmed/33072846 http://dx.doi.org/10.1002/dad2.12101 |
Ejemplares similares
-
Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab
por: VandeVrede, Lawren, et al.
Publicado: (2023) -
APOE ε4 and resting‐state functional connectivity in racially/ethnically diverse older adults
por: Turney, Indira C., et al.
Publicado: (2020) -
Longitudinal association between hippocampus atrophy and episodic‐memory decline in non‐demented APOE ε4 carriers
por: Gorbach, Tetiana, et al.
Publicado: (2020) -
Familiarity deficits in cognitively normal aging individuals with APOE ε4: A follow-up investigation of medial temporal lobe structural correlates
por: Schoemaker, Dorothee, et al.
Publicado: (2017) -
Association of APOE Serum Levels and APOE ε2, ε3, and ε4 Alleles with Optic Neuritis
por: Momkute, Liucija, et al.
Publicado: (2022)